Editorial Board Member
Richard S. Finn
Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
HomePage
Research Interests
molecular therapies for hepatocellular carcinoma, systemic therapy, therapeutic strategies